The meiotic recombination checkpoint delays gamete precursors in G2 until DNA breaks created during recombination are repaired and chromosome structure has been restored. Here, we show that the FK506 binding protein Fpr3 prevents premature adaptation to damage and thus serves to maintain recombination checkpoint activity. Impaired checkpoint function is observed both in cells lacking FPR3 and in cells treated with rapamycin, a small molecule inhibitor that binds to the proline isomerase (PPIase) domain of Fpr3. FPR3 functions in the checkpoint through controlling protein phosphatase 1 (PP1). Fpr3 interacts with PP1 through its PPIase domain, regulates PP1 localization, and counteracts the activity of PP1 in vivo. Our findings define a branch of the recombination checkpoint involved in the adaptation to persistent chromosomal damage and a critical function for FK506 binding proteins during meiosis.
Introduction

FK506 binding proteins (FKBPs
. Although the basis of these defects is not understood, these observations raise the possibility that a role of FKBPs in gametogenesis is conserved across species.
Meiosis, a central event in gametogenesis, is a specialized cell division where two rounds of chromosome segregation, meiosis I and meiosis II, follow a single round of chromosome duplication, leading to the separation of homologous chromosomes and sister chromatids, respectively. Faithful segregation of homologous chromosomes requires their physical connection through interhomolog recombination. Recombination is initiated by the introduction of DNA double-strand breaks (DSBs) by the transesterase Spo11 (Keeney, 2001). DSBs are subsequently repaired using the homologous chromosome as a template because repair off of the sister chromatid is blocked (reviewed in Petes and Pukkila, 1995; Zickler and Kleckner, 1999). One important factor for meiotic DSB repair is Dmc1, a homolog of the bacterial DNA strand invasion factor RecA, which serves to direct nascent DSB toward the homologous chromo-
some (Bishop et al., 1992; Schwacha and Kleckner, 1997). Absence of Dmc1 leads to the accumulation of unrepaired DSBs and a checkpoint-dependent delay in meiotic G2 (Bishop et al., 1992).
If broken chromosomes persist, a conserved meiotic surveillance mechanism called the recombination or pachytene checkpoint delays cell cycle progression in meiotic G2 (Lydall et al., 1996; Roeder and Bailis, 2000). In budding yeast, the G2 delay is brought about by the inhibition of cyclin dependent kinase (CDK) activity (Roeder and Bailis, 2000) and by preventing activation of the transcription factor Ndt80, which induces the expression of factors necessary for meiotic chromosome segregation and spore formation (Pak and Segall, 2002; Tung et al., 2000) . Factors implicated in the recombination checkpoint in yeast include components of the mitotic DNA damage signaling machinery (Mec1, Rad24, Rad17, Mec3, and Ddc1), several meiosis-specific chromosomal proteins (Red1, Hop1, and Mek1), and a number of nucleolar proteins (Pch2, Sir2, and Glc7; reviewed in Roeder and Bailis, 2000) . Yeast protein phosphatase 1 (PP1), Glc7, is not a checkpoint component per se but is thought to promote resumption of the cell cycle after recombination checkpoint-dependent delay, by reversing phosphorylation events put in place by the checkpoint kinase Mek1 (Bailis and Roeder, 2000) .
In a systematic search for novel recombination checkpoint components, we identified the yeast FKBP Fpr3 as being required for continued cell cycle arrest. Using point mutants and rapamycin, we demonstrate that the proline isomerase domain but not its PPIase activity is required for the protein's checkpoint function. Our data also provide insight into the mechanism whereby Fpr3 functions in the recombination checkpoint. Fpr3 associates with protein phophatase 1 through its proline isomerase domain and inhibits PP1 function in vivo. We propose that Fpr3 acts as an inhibi-tor of PP1, thereby preventing premature adaptation to chromosomal damage. We first compared the kinetics with which dmc1D and dmc1D fpr3D cells progressed through meiosis, using the timing of cyclin Clb3 protein accumulation and spindle pole body (SPB) separation as markers to assess progression out of meiotic G2 into prometaphase I. Clb3 accumulation was strongly delayed in dmc1D cells, compared to wild-type cells, and was accelerated when FPR3 was deleted ( Figure 1A ). We note, however, that compared to wild-type cells and fpr3D mutants, a 3 hr delay in Clb3 accumulation persisted in dmc1D fpr3D cells ( Figure 1A ). The separation of SPBs occurred with similar kinetics as Clb3 accumulation. dmc1D fpr3D cells initiated SPB separation 7 hr after transfer into sporulation medium, whereas little separation occurred in dmc1D mutants ( Figure 1B) . Finally, sporulation efficiency increased dramatically when FPR3 was deleted in dmc1D cells ( Figure 1C ). Our data show that deletion of FPR3 allows dmc1D cells to escape the checkpoint-dependent G2 block and to complete the meiotic program.
Results
FPR3
The suppression of the checkpoint block in the absence of FPR3 is not restricted to dmc1D mutants. Deletion of FPR3 accelerated the timing of entry into meiosis I for hop2D, rec8D, mer3D, and rad50S cells (Alani et al., 1990; Klein et al., 1999; Leu et al., 1998; Nakagawa and Ogawa, 1999) ( Figures 1D-1G) . However, as observed in dmc1D cells, deletion of FPR3 did not eliminate the G2 delay, suggesting that some aspects of the recombination checkpoint were still functional in the absence of FPR3. Interestingly, deletion of FPR3 did not allow zip1D mutants (Sym et al., 1993) to exit the G2 block more effectively, but instead appeared to slightly exaggerate it ( Figure 1H ). The reason why some but not all blocks are bypassed by deleting FPR3 is at present unclear. The situation is likely more complex as suggested by the recent finding that zip1D and mer3D mutants have very similar phenotypes at low (23°C) and high (33°C) temperatures but differ at the intermediate temperature (30°C) used in this study (Borner et al., 2004) . Our findings nevertheless suggest that the prophase delay observed in zip1D cells (at 30°C) is qualitatively different from the delays caused by the deletions of DMC1, HOP2, REC8, or MER3.
We next asked whether overexpression of FPR3 Despite the lack of crossover repair, dmc1D fpr3D cells entered meiosis I after only a 2 hr delay compared to wild-type and fpr3D single mutants, and 3-4 hr before significant spindle formation could be observed in dmc1D mutants ( Figure 2B ). Consistent with the lack of DNA repair, we found that deletion of FPR3 also did not rescue the defect of dmc1D cells in synaptonemal complex formation ( Figure S2 ). Our results indicate that deletion of FPR3 neither eliminates DSB formation nor allows crossover repair of DSBs from the homolog in dmc1D cells, while still allowing progression through meiosis.
FPR3 Is a Checkpoint Factor DSB repair using the sister chromatid as a template is largely inhibited during meiotic recombination, making homologous chromosomes the preferred repair template (Petes and Pukkila, 1995; Schwacha and Kleckner, 1997). We took several approaches to test the possibility that deletion of FPR3 allows repair of DSBs from the sister chromatid in dmc1D mutants. First, repair of DSBs is expected to improve the spore viability of dmc1D mutants. We performed this experiment in a spo13D background because cells lacking SPO13 undergo a single round of chromosome segregation, which partially alleviates the requirement for crossover recombination and chiasma formation (Wagstaff et al., 1982). Thus, if repair of DSBs were to occur from the sister chromatid, spo13D fpr3D dmc1D spores ought to exhibit increased viability over spo13D dmc1D spores. This, however, was not the case (Table S1 ), indicating that deletion of FPR3 does not allow significant repair off the sister chromatid in dmc1D mutants. Because When both MATa and MATa information was provided, haploid cdc6-mn cells initiated meiotic recombination with only a single copy of their genome ( Figure  3A ). These cells possessed the full meiotic repair machinery but lacked a template to repair the DSBs and exhibited a cell cycle delay. The delay was DSB dependent because deletion of SPO11, the enzyme that catalyzes DSB formation (Keeney, 2001), allowed MATa/a cdc6-mn haploids to progress through meiosis with kinetics indistinguishable from cells with a full set of repair templates ( Figure 3A) . If deletion of FPR3 were to only activate repair from the sister chromatid, it would be expected to have no effect on the cell cycle pro- FPR3 and PCH2 Do Not Function Together in the Recombination Checkpoint Pch2, like Fpr3, is found in the nucleolus (San-Segundo and Roeder, 1999), which raised the possibility that the two proteins act in a common pathway. However, the effects of deleting FPR3 and PCH2 on the G2 delays of recombination mutants were not identical. Deletion of FPR3 alleviated the prophase delay of dmc1D but not zip1D mutants (Figure 1) . Deletion of PCH2 allowed zip1D mutants to enter meiosis I (San-Segundo and Roeder, 1999), whereas it enhanced the prophase block of dmc1D cells (Figures 5A and 5B) . These results indicate that, at least at 30°C, the G2 delays of zip1D and dmc1D mutants are not caused by the same mechanism.
PCH2 may be a component of a checkpoint pathway acting in parallel to the checkpoint response defined by FPR3. However, several lines of evidence argue against this possibility and instead support a role for PCH2 in DSB repair. First, pch2D cells themselves exhibited a two-hour delay in cell cycle progression (San-Segundo and Roeder, 1999) that could not be bypassed by the deletion of FPR3 ( Figure 5C ). Second, while DSBs have largely disappeared by 4 hr in wild-type cells (Figure  2A) , they persisted at least until the 6 hr time point in pch2D mutants ( Figure S7) . Accordingly, crossover repair products were also observed with a 2 hr delay. Moreover, the DSBs of dmc1D pch2D mutants did not get hyperresected as rapidly as in dmc1D cells (compare Figure S7 with Figure 2A) . Together, these findings indicate that PCH2 has a role in the processing of DSBs in both wild-type and dmc1D mutants, which argues against a common role of PCH2 and FPR3 in the recombination checkpoint.
Fpr3
Associates with and Anchors Glc7/PP1 in the Nucleolus PP1/Glc7 is a checkpoint factor (Bailis and Roeder, 2000) that, like Fpr3, is expressed during both mitosis and meiosis and found enriched in the nucleolus during mitotic growth (Bloecher and Tatchell, 2000). Furthermore, a large-scale affinity purification study showed that Fpr3 copurifies with a subset of nucleolar factors one of which is Glc7 (Ho et al., 2002) . We therefore examined whether Fpr3 and Glc7 form a complex. Fpr3 forms a complex with Glc7 during mitosis ( Figure 6C ) and meiosis ( Figure 6D ) as evident from their ability to coimmunoprecipitate from both mitotic and meiotic extracts. Consistent with this, Glc7 co-localized with the nucleolar pool of Fpr3 on chromatin spreads of nuclei obtained from mitotically dividing and early meiotic cells (Figures 6A and 6B) . Furthermore, Fpr3 was required for Glc7 association with the nucleolus in both mitotic and early meiotic cells ( Figure 6B , and data not shown). The loss of Glc7 from the nucleolus was not due to a general disorganization of the organelle, as Nop1 localization was not affected by deletion of FPR3 ( Figure S8 ).
As cells enter the meiotic program, both Fpr3 and Glc7 leave their nucleolar compartment and spread throughout the nucleus (Figures 4D and 6B) , such that at later stages in meiosis, when the nucleolar signal of Fpr3 becomes restricted to a single dot, Glc7 cannot be detected in the nucleolus anymore (Bailis and Roeder, 2000). Nevertheless, Glc7 and Fpr3 remained in a complex throughout meiosis ( Figure 6D ), indicating that they remained in the nucleoplasm as a complex. Interestingly, we observed a transient increase in coimmunoprecipitation efficiency in extract obtained from dmc1D cells as compared to wild-type cells around the time of DSB formation (3 hr time point, Figure 6D ), which may point to a functional connection between these two proteins within the recombination checkpoint. Our attempts to reproduce the interaction between Fpr3 and Glc7 using recombinant proteins were not successful indicating either that Fpr3 and Glc7 do not interact directly, or that Fpr3 and/or Glc7 need to be modified in order to interact. Consistent with the latter idea is the observation that Glc7 appeared to preferentially associate with a slower migrating form of Fpr3 (arrow, Figure 6D 
Fpr3 Antagonizes Glc7 Function
FPR3 is required for maintained recombination checkpoint-induced cell cycle delay. In contrast, GLC7 is required for the adaptation to DNA damage and overproduction of the phosphatase allows cells to bypass the recombination checkpoint delay (Bailis and Roeder, 2000). These findings together with our observation that the two proteins form a complex raise the possibility that Fpr3 functions as an inhibitor of Glc7. Consistent with this idea, we found that overexpression of FPR3 suppressed the lethality caused by high levels of GLC7 ( Figure 6E ). The suppression of the GLC7-induced lethality was not simply a result of lowering GLC7 expression from the GAL1-10 promoter, due to the presence of an additional copy of this promoter, because introduction of a GAL1-10 promoter alone did not suppress the lethality associated with overexpressing GLC7.
Overexpression of FPR3 also counteracted Glc7 ac- As a final test of the importance of Fpr3's isomerase domain in the recombination checkpoint, we examined the effects of two well-characterized small molecule inhibitors of Fpr3, FK506 and rapamycin, on the recombination checkpoint-induced G2 delay. Treatment of dmc1D cells with either FK506 or rapamycin allowed them to progress through the meiotic divisions ( Figures  7F and S10) . Rapamycin exhibited its effect at substantially lower doses than FK506 ( Figure S10 ). Selectivity for rapamycin has previously been observed for Fpr3 (Shan et al., 1994) . Drug addition specifically affected Fpr3 and not other checkpoint factors because exposure to rapamycin bypassed the dmc1D arrest to levels similar to those observed when FPR3 was deleted. Moreover, the effect of rapamycin was not enhanced by a deletion of FPR3 indicating that rapamycin acted by inhibiting Fpr3 (Figure 7F ). Taken together, the effects of Fpr3 point mutations and rapamycin on the recombination checkpoint indicate that the proline isomerase domain of Fpr3 but not its isomerase activity is required for the protein's checkpoint function.
(C and D) Western blots detecting Fpr3 after immunoprecipitation of Glc7-myc from (C) cycling mitotic cells (A6030) or (D) cells progressing through meiosis; WT (A12444), dmc1D (A12445). The arrow indicates a meiosis-specific modification of Fpr3. (E) Segregants of a cross between pGAL-GLC7 cells with pGAL-FPR3 cells (A1631 × A12368, W303). Tetrads were micromanipulated on
Discussion
Fpr3 Is a Component of the Recombination Checkpoint
The recombination checkpoint is a conserved meiosisspecific surveillance mechanism (Roeder and Bailis, 2000) . In the present study, we identified the FK506 and rapamycin binding protein Fpr3 as being required for maintained checkpoint arrest. Many meiotic checkpoint factors, in particular the components of the canonical mitotic DNA damage checkpoint machinery, Rad24, Rad17, Mec3, Ddc1, and Mec1, while being important sensors and transducers of the DNA damage signal in mitotic cells, have a poorly understood second role during meiosis in preventing DSB repair from the sister chromatid (Grushcow et al., 1999; Thompson and Stahl, 1999) . Separating checkpoint and repair functions for these factors during meiosis has generally not been trivial. Here, we developed a tool to analyze the checkpoint contribution of any putative recombination checkpoint factor independently of its repair function. By constructing haploid cells that do not replicate their genome but still enter the meiotic program, we eliminated all homologous repair templates for meiotic recombination-the sister chromatid as well as the homologous chromosomes. This allowed us to unambiguously classify FPR3 as a checkpoint factor. The same assay will be very helpful in evaluating the checkpoint roles of factors that also function to promote DSB repair. Together, our data suggest a model in which FPR3 maintains the checkpoint arrest by antagonizing GLC7 function. This idea is consistent with our observation that the partial alleviation of the checkpoint delay in dmc1D cells by overexpression of GLC7 is only insignificantly enhanced by the additional deletion of FPR3. The fact that inactivation of FPR3 only bypasses the arrests of dmc1D, hop2D, rec8D, and mer3D mutants after an initial delay is also consistent with the above model. Because FPR3 does not affect the checkpoint pathway itself, the checkpoint signal remains active in these mutants and could be responsible for the initial delay. Unrestrained Glc7 activity would however eventually override the checkpoint arrest and promote entry into the meiotic divisions. It has not escaped our attention that this model of Glc7 regulation is reminiscent of the regulation of the protein phosphatase Cdc14, which is kept inactive in the nucleolus by an inhibitory subunit Cfi1/Net1 (Stegmeier and Amon, 2004) . The finding that the nucleolar structure occupied by Fpr3 and Glc7 differs from that occupied by Cdc14 furthermore raises the interesting possibility that distinct domains of the nucleolus may serve different signaling functions.
What Is the Function of Fpr3 in the Recombination
Based on our observations, we propose FPR3 and GLC7 function in the adaptation to persistent DNA damage. Adaptation, that is, continued cell cycle progression after an initial arrest even if the DNA damage remains, is a phenomenon that has been studied in yeast and vertebrates ( 
Screen, Growth Conditions, and Drug Treatment
The screening procedure was based on a screen conducted by (Marston et al., 2004) and is described in detail in Figure S1 . Conditions for α-factor release were as described (Visintin et al., 1999). Synchronous meioses were conducted as described (Marston et al., 2003) . 
Immunofluorescence and Spreads
Recombinant Fpr3 and PPIase Measurements
Recombinant wild-type and mutant Fpr3 were expressed as GSTfusion proteins at 30°C. Cells were lysed by sonication in 50 mM Tris (pH 7.4) (+0.5 mM DTT and complete protease inhibitors [Roche]). GST-Fpr3 was purified over Q sepharose (100 mM − 640 mM NaCl gradient). The peak fraction was applied to glutathione sepharose 4B (Amersham) and recombinant Fpr3 was released from the beads by thrombin cleavage at room temperature. PPIase activity of 50 g recombinant Fpr3 was assayed following the procedure of Shan et al. (1994) using Suc-Ala-Leu-Pro-Phe-pNA (BACHEM) as a substrate. PPIase activity was observed at 4°C in a CARY 50 Bio UV-Vis Spectrophotometer (Varian) at 395 nm. The resulting data points were fit to first order kinetics.
Other Techniques
Southern blot analysis was conducted as described by Hunter and Kleckner (2001). Blots were quantified using ImageQuant software (Amersham Biosciences). Fpr3 was modeled on the crystal structures of homologous FKBPs using SwissModel (Guex and Peitsch, 1997; Peitsch, 1995; Peitsch, 1996) and visualized using DS Viewer Pro software (accelrys). Flow cytometric analysis of total cellular DNA content and Western analysis were performed as described in (Visintin et al., 1998). For Western analysis, C-terminal α-Fpr3 antibody was used at a dilution of 1:2500 and α-Cdc28 was used at 1:1000. 
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